Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade

European Journal of Clinical Pharmacology

Volumn 63, Issue 7, 2007, Pages 721-722

  Peynaud, Delphine ^a   Charpiat, Bruno ^a   Vial, Thierry ^b   Gallavardin, Michel ^c   Ducerf, Christian ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b Regional Pharmacovigilance Center   (France)

^c Cardiology Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; NICARDIPINE; OMEPRAZOLE; TACROLIMUS;

ADULT; CARDIOVASCULAR SYMPTOM; CASE REPORT; DRUG BLOOD LEVEL; DRUG OVERDOSE; DRUG WITHDRAWAL; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOOD DRUG INTERACTION; FOOD INTAKE; GRAPEFRUIT; HOSPITAL ADMISSION; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER METABOLISM; LIVER TRANSPLANTATION; MALE; ORANGE (FRUIT); PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX PAIN;

CITRUS PARADISI; FOOD-DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MIDDLE AGED; OVERDOSE; TACROLIMUS;

EID: 34250338903     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0323-3     Document Type: Letter

References (11)

1. Bailey DG, Spence JD, Munoz C, Arnold JM (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268-269
2. Egashira K, Fukuda E, Onga T et al. (2003) Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. Transplantation 75:1057
3. Fukatsu S, Fukudo M, Masuda S et al. (2006) Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient. Drug Metab Pharmacokinet 21:122-125
4. Egashira K, Ohtani H, Itoh S et al. (2004) Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein. Drug Metab Dispos 32:828-833
5. Kane GC, Lipsky JJ (2000) Drug-grapefruit juice interactions. Mayo Clin Proc 75:933-942
6. Lohezic-Le Devehat F, Marigny K, Doucet M, Javaudin L (2002) Grapefruit juice and drugs: a hazardous combination? Therapie 57:432-445
7. Monnier G, Charpiat B, Serratrice F, Bossaert S, Fourcade N, Ducerf C (2003) Evaluation of drug therapy knowledge in liver transplant patients after pharmacy counseling. Therapie 58:305-311
8. FK506 Kidney Transplant Study Group (1994) Early phase II study of FK506 (tacrolimus) for kidney transplantation. Jpn J Transplant 29:294-313
9. FK506 Kidney Transplant Study Group (1994) Late phase II study of FK506 (tacrolimus) for kidney transplantation. Jpn J Transplant 29:614-631
10. FK506 Kidney Transplant Study Group (1994) Phase III study of FK506 (tacrolimus) for kidney transplantation. Jpn J Transplant 29:650-681
11. Seino Y, Hori M, Sonoda T (2003) Multicenter prospective investigation on cardiovascular adverse effects of tacrolimus in kidney transplantations. Cardiovasc Drugs Ther 17:141-149